Edition:
United States

FDA approves Pfizer's Lyrica® CR extended-release tablets CV


Thursday, 12 Oct 2017 08:00am EDT 

Oct 12 (Reuters) - Pfizer Inc :Pfizer Inc - ‍U.S. FDA approves Lyrica CR extended-release tablets CV​.Says ‍Lyrica CR did not receive approval for management of fibromyalgia​.Pfizer inc - ‍lyrica cr did not receive approval for management of fibromyalgia​.Pfizer - in PHN study, 73.6% of patients in Lyrica CR group achieved at least 50% improvement in pain intensity compared with 54.6% in placebo group. 

Company Quote

35.35
-0.02 -0.06%
20 Nov 2017